Ancora Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-155,168
Closed -$2.63M 547
2014
Q4
$2.63M Buy
+155,168
New +$2.18M 0.32% 79

Ancora Advisors's AVNR Position: Q1 2015 in Review

Ancora Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 155,168 shares — an estimated $2.63M sold.

Ancora Advisors first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $2.63M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Ancora Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Ancora Advisors sold 155,168 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.63M.
  • Ancora Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Ancora Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.63M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Ancora Advisors's 13F filing for Q1 2015, filed 15 May 2015.